CA Stock MarketDetailed Quotes

Biosenta Inc (ZRO)

Watchlist
  • 0.060
  • 0.0000.00%
15min DelayMarket Closed May 14 09:30 ET
2.09MMarket Cap-0.75P/E (TTM)

Biosenta Inc (ZRO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.62%-173.57K
41.57%-455.38K
-72.34%-92.7K
61.31%-76.17K
42.23%-104.53K
47.67%-181.98K
-41.50%-779.35K
56.77%-53.79K
-19.97%-196.87K
-120.11%-180.93K
Net income from continuing operations
-1.42%-595.85K
-12.49%-2.51M
10.59%-638.57K
-9.63%-599.98K
-37.32%-679.81K
-24.70%-587.49K
64.64%-2.23M
86.34%-714.18K
-10.69%-547.3K
-47.00%-495.07K
Depreciation and amortization
-9.81%570
-19.75%2.34K
-18.50%542
-18.57%570
-61.44%600
--632
--2.92K
--665
--700
--1.56K
Asset impairment expenditure
----
----
----
----
----
----
--0
----
----
----
Remuneration paid in stock
-50.41%37.5K
402.73%317.73K
1,421.74%87.5K
-27.11%37.5K
1,851.67%117.1K
--75.63K
-62.52%63.2K
--5.75K
-64.08%51.45K
-40.10%6K
Other non cashItems
-6.24%284.06K
-0.09%1.1M
-67.43%177.78K
134.08%314.63K
3.75%308.91K
137.83%302.95K
262,641.81%1.11M
--545.76K
--134.41K
--297.76K
Change In working capital
280.74%100.15K
126.12%626.14K
158.79%280.05K
4.42%171.11K
1,584.31%148.67K
756.12%26.3K
-64.97%276.91K
-65.36%108.22K
-13.81%163.87K
-96.35%8.83K
-Change in receivables
112.52%432
238.94%36.13K
-84.34%33.27K
101.84%3.12K
106.06%3.19K
78.95%-3.45K
-78.53%-26.01K
7,317.10%212.5K
-159,808.49%-169.5K
-2,695.43%-52.61K
-Change in inventory
-55.11%101
-35.69%899
-65.93%186
73.12%322
-69.60%166
87.50%225
-33.14%1.4K
128.44%546
-94.98%186
223.08%546
-Change in prepaid assets
--0
-58.36%7.66K
--0
--0
-33.42%3.06K
0.00%4.6K
0.00%18.38K
0.00%4.6K
0.00%4.6K
0.00%4.6K
-Change in payables and accrued expense
299.52%99.62K
105.36%581.46K
325.36%246.6K
-48.97%167.67K
152.70%142.26K
225.13%24.93K
-63.91%283.13K
-135.66%-109.42K
80.61%328.59K
-76.41%56.3K
Cash from discontinued investing activities
Operating cash flow
4.62%-173.57K
41.57%-455.38K
-72.35%-92.7K
61.31%-76.17K
42.23%-104.53K
47.67%-181.98K
-41.50%-779.35K
56.77%-53.79K
-19.97%-196.87K
-120.11%-180.93K
Investing cash flow
Cash flow from continuing investing activities
93.63%-1.65K
-25.86K
0
0
0
-25.86K
0
0
0
0
Capital expenditure reported
----
----
----
----
----
----
--0
----
----
----
Net PPE purchase and sale
93.63%-1.65K
---25.86K
--0
--0
--0
---25.86K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
93.63%-1.65K
---25.86K
--0
--0
--0
---25.86K
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-36.06%156.54K
-36.16%499.2K
104.39%114.5K
-59.29%76.5K
22.89%63.39K
-49.68%244.81K
43.49%782K
-52.35%56.02K
1.79%187.9K
-25.03%51.59K
Net issuance payments of debt
-36.06%156.54K
264.22%499.2K
104.39%114.5K
118.56%76.5K
22.89%63.39K
47,343.02%244.81K
-209.17%-303.98K
-55.06%56.02K
-462.15%-412.1K
4,025.80%51.59K
Net common stock issuance
----
--0
--0
--0
--0
--0
--1.1M
--0
--600K
--0
Net other financing activities
----
----
----
----
--251
97.19%-394
-105.26%-14.03K
99.92%-6
--0
--0
Cash from discontinued financing activities
Financing cash flow
-36.06%156.54K
-36.16%499.2K
104.42%114.5K
-59.21%76.64K
22.62%63.25K
-49.68%244.81K
43.49%781.99K
-52.35%56.01K
1.79%187.9K
-25.03%51.59K
Net cash flow
Beginning cash position
210.61%26.49K
44.98%8.53K
-25.58%4.69K
-72.39%4.22K
-68.54%45.49K
44.98%8.53K
-78.42%5.88K
-77.74%6.3K
95.49%15.27K
582.19%144.61K
Current changes in cash
-150.53%-18.68K
578.87%17.96K
878.99%21.8K
105.30%475
68.09%-41.28K
-73.35%36.97K
112.38%2.65K
109.93%2.23K
-143.74%-8.97K
-866.11%-129.34K
End cash Position
-82.83%7.81K
210.61%26.49K
210.61%26.49K
-25.58%4.69K
-72.39%4.22K
-68.54%45.49K
44.98%8.53K
44.98%8.53K
-77.74%6.3K
95.49%15.27K
Free cash from
15.70%-175.22K
38.25%-481.24K
-72.35%-92.7K
61.31%-76.17K
42.23%-104.53K
40.24%-207.84K
-37.61%-779.35K
61.57%-53.79K
-19.97%-196.87K
-120.11%-180.93K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.62%-173.57K41.57%-455.38K-72.34%-92.7K61.31%-76.17K42.23%-104.53K47.67%-181.98K-41.50%-779.35K56.77%-53.79K-19.97%-196.87K-120.11%-180.93K
Net income from continuing operations -1.42%-595.85K-12.49%-2.51M10.59%-638.57K-9.63%-599.98K-37.32%-679.81K-24.70%-587.49K64.64%-2.23M86.34%-714.18K-10.69%-547.3K-47.00%-495.07K
Depreciation and amortization -9.81%570-19.75%2.34K-18.50%542-18.57%570-61.44%600--632--2.92K--665--700--1.56K
Asset impairment expenditure --------------------------0------------
Remuneration paid in stock -50.41%37.5K402.73%317.73K1,421.74%87.5K-27.11%37.5K1,851.67%117.1K--75.63K-62.52%63.2K--5.75K-64.08%51.45K-40.10%6K
Other non cashItems -6.24%284.06K-0.09%1.1M-67.43%177.78K134.08%314.63K3.75%308.91K137.83%302.95K262,641.81%1.11M--545.76K--134.41K--297.76K
Change In working capital 280.74%100.15K126.12%626.14K158.79%280.05K4.42%171.11K1,584.31%148.67K756.12%26.3K-64.97%276.91K-65.36%108.22K-13.81%163.87K-96.35%8.83K
-Change in receivables 112.52%432238.94%36.13K-84.34%33.27K101.84%3.12K106.06%3.19K78.95%-3.45K-78.53%-26.01K7,317.10%212.5K-159,808.49%-169.5K-2,695.43%-52.61K
-Change in inventory -55.11%101-35.69%899-65.93%18673.12%322-69.60%16687.50%225-33.14%1.4K128.44%546-94.98%186223.08%546
-Change in prepaid assets --0-58.36%7.66K--0--0-33.42%3.06K0.00%4.6K0.00%18.38K0.00%4.6K0.00%4.6K0.00%4.6K
-Change in payables and accrued expense 299.52%99.62K105.36%581.46K325.36%246.6K-48.97%167.67K152.70%142.26K225.13%24.93K-63.91%283.13K-135.66%-109.42K80.61%328.59K-76.41%56.3K
Cash from discontinued investing activities
Operating cash flow 4.62%-173.57K41.57%-455.38K-72.35%-92.7K61.31%-76.17K42.23%-104.53K47.67%-181.98K-41.50%-779.35K56.77%-53.79K-19.97%-196.87K-120.11%-180.93K
Investing cash flow
Cash flow from continuing investing activities 93.63%-1.65K-25.86K000-25.86K0000
Capital expenditure reported --------------------------0------------
Net PPE purchase and sale 93.63%-1.65K---25.86K--0--0--0---25.86K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 93.63%-1.65K---25.86K--0--0--0---25.86K--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -36.06%156.54K-36.16%499.2K104.39%114.5K-59.29%76.5K22.89%63.39K-49.68%244.81K43.49%782K-52.35%56.02K1.79%187.9K-25.03%51.59K
Net issuance payments of debt -36.06%156.54K264.22%499.2K104.39%114.5K118.56%76.5K22.89%63.39K47,343.02%244.81K-209.17%-303.98K-55.06%56.02K-462.15%-412.1K4,025.80%51.59K
Net common stock issuance ------0--0--0--0--0--1.1M--0--600K--0
Net other financing activities ------------------25197.19%-394-105.26%-14.03K99.92%-6--0--0
Cash from discontinued financing activities
Financing cash flow -36.06%156.54K-36.16%499.2K104.42%114.5K-59.21%76.64K22.62%63.25K-49.68%244.81K43.49%781.99K-52.35%56.01K1.79%187.9K-25.03%51.59K
Net cash flow
Beginning cash position 210.61%26.49K44.98%8.53K-25.58%4.69K-72.39%4.22K-68.54%45.49K44.98%8.53K-78.42%5.88K-77.74%6.3K95.49%15.27K582.19%144.61K
Current changes in cash -150.53%-18.68K578.87%17.96K878.99%21.8K105.30%47568.09%-41.28K-73.35%36.97K112.38%2.65K109.93%2.23K-143.74%-8.97K-866.11%-129.34K
End cash Position -82.83%7.81K210.61%26.49K210.61%26.49K-25.58%4.69K-72.39%4.22K-68.54%45.49K44.98%8.53K44.98%8.53K-77.74%6.3K95.49%15.27K
Free cash from 15.70%-175.22K38.25%-481.24K-72.35%-92.7K61.31%-76.17K42.23%-104.53K40.24%-207.84K-37.61%-779.35K61.57%-53.79K-19.97%-196.87K-120.11%-180.93K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More